Clinical and electroencephalographic effects of cinanserin in schizophrenic and manic patients
Itil, T.M.; Polvan, N.; Holden, J.M.
Diseases of the Nervous System 32(3): 193-200
1971
ISSN/ISBN: 0012-3714 PMID: 4929084 Document Number: 35316
Document emailed within 1 workday
Related Documents
Mosolov, S.N.; Zaĭtsev, S.G. 1989: Significance of the clinical characteristics of manic, manic- paranoid and manic-hebephrenic conditions for differentiated psychopharmacotherapy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(4): 87-93Prilipko, L.L.; Erin, A.N.; Beliaev, B.S.; Piatnitskiĭ, A.N.; Siuniakov, S.A. 1987: Activation of lipid peroxidation in the bodies of schizophrenic and manic-depressive patients Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(1): 100-103
Haase, H.J. 1979: Ambulatory continuing care of mental patients with manic depressive and schizophrenic psychoses Zfa. Zeitschrift für Allgemeinmedizin 55(16): 963-971
Gillin, J.C.; Kaplan, J.A.; Wyatt, R.J. 1976: Clinical effects of tryptophan in chronic schizophrenic patients Biological Psychiatry 11(5): 635-639
Bochkarev, V.K.; Neznamov, G.G. 1995: The correlation of the electroencephalographic and clinical effects of benzodiazepine tranquilizers in patients with mental disorders at the neurotic level Eksperimental'naia i Klinicheskaia Farmakologiia 58(4): 18-22
Volobueva, E.G. 1972: Clinical and electroencephalographic parallels in patients with tuberculosis of the lungs exhibiting side effects produced by antibacterial preparations Problemy Tuberkuleza 50(8): 31-36
Asada, S.; Ishimaru, T.; Kubo, S.; Kodama, H.; Masuda, K. 1976: Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method L'Encephale 2(1): 73-83
Hunger, J. 1974: Electroencephalographic findings in schizophrenic psychoses Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 114(1): 135-146
Svestka, J.; Náhunek, K. 1989: Therapeutic results in acute phases of manic depressive and schizophrenic psychoses as possible predictors of the prophylactic effect Activitas Nervosa Superior 31(1): 51-52
Rybakowski, J.; Trzebiatowska-Trzeciak, O. 1975: Prophylactic and therapeutic effects of lithium as related to heredity factors in patients with manic-depressive psychosis Psychiatria Polska 9(5): 503-508
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Cheliapina, M.V.; Sharova, E.V.; Zaĭtsev, O.S. 2011: Clinical and electroencephalographic effects of amantadine sulfate (PK-Merz) on consciousness disorders due to the severe traumatic brain injury Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(5): 24-29
Rybnikov, A.I.; Zhirmunskaia, E.A.; Veĭn, A.M. 1978: Clinical electroencephalographic correlations in autonomic disorders in neurosis patients Voenno-Meditsinskii Zhurnal 5: 67-70
Navas, E.; Sariego, M.; Luis, J.C.; Crespo, A.; Federero, F.; Sánchez-Peña, J. 1993: Electroencephalographic effects of subhypnotic doses of midazolam in healthy subjects and in brain disease patients Revista Espanola de Anestesiologia y Reanimacion 40(2): 86-89
Sanga, M.; Kurotani, M.; Nomura, S. 1999: Effects of demeclocycline on psychiatric polydipsia in schizophrenic patients Nihon Shinkei Seishin Yakurigaku Zasshi 19(1): 21-26
Volavka, J. 1999: The effects of clozapine on aggression and substance abuse in schizophrenic patients Journal of Clinical Psychiatry 60(Suppl): 43-46
Breier, A.; Wolkowitz, O.M.; Rapaport, M.; Paul, S.M.; Pickar, D. 1988: Metabolic stress effects in normal volunteers and schizophrenic patients Psychopharmacology Bulletin 24(3): 431-433
Davidson, M.; Losonczy, M.F.; Mohs, R.C.; Powchick, P.; Freed, L.B.; Kaminsky, R.; Davis, K.L. 1987: Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients Psychopharmacology Bulletin 23(3): 407-410
Carlsson, C.; Dencker, S.J.; Grimby, G.; Häggendal, J.; Johnsson, G. 1976: Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise International Journal of Clinical Pharmacology and Biopharmacy 13(4): 262-268
Bratek, A.; Koźmin-Burzyńska, A.; Krysta, K.; Cierpka-Wiszniewska, K.; Krupka-Matuszczyk, I. 2015: Effects of hormones on cognition in schizophrenic male patients--preliminary results Psychiatria Danubina 27(Suppl 1): S261-S265